IP Library › Granted Patent US 8,697,439
Granted Patent B2
US 8,697,439 · App. 13/505,506 · Granted Apr 15, 2014

Direct protein delivery with engineered microvesicles

Inventors: Philippe Mangeot (Lyons Cedex, FR); Vincent Lotteau (Lyons Cedex, FR)
Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,439
App. No.
13/505,506
Granted
Apr 15, 2014
Kind
B2
Abstract

The present invention relates to direct protein delivery with engineered micro vesicles.

Claims (5)

1. An in vitro method of delivering a protein of interest into a target cell comprising culturing a target cell with an isolated eukaryotic cell overexpressing a viral membrane fusion protein and a protein of interest, wherein said eukaryotic cell secretes microvesicles comprising said viral membrane fusion protein and a protein of interest, wherein said eukaryotic cell does not express any viral structural proteins and said protein of interest is not covalently bonded to said viral membrane fusion protein, and wherein said microvesicles secreted by said eukaryotic cell contact said target cell and deliver said protein of interest into said target cell.

2. The method according to claim 1 , wherein several proteins of interest are delivered into said target cell by culturing said target cell with several of said eukaryotic cell each overexpressing a different protein of interest.

3. The method according to claim 1 , wherein said protein of interest is a membrane receptor.

4. The method according to claim 1 , wherein said protein of interest is a transcription factor.

5. A method of rendering a target cell transiently permissive to an ecotropic viral particle comprising contacting a target cell with a microvesicle comprising a viral fusion protein and an ecotrophic viral receptor (EcoR), wherein said contacting delivers said EcoR into said target cell and renders said target cell transiently permissive to an ecotropic viral particle, wherein said microvesicle is produced by an isolated eukaryotic cell overexpressing a viral membrane fusion protein and said EcoR, wherein said eukaryotic cell secretes said microvesicles, and wherein said eukaryotic cell does not express any viral structural proteins and said EcoR is not covalently bonded to said viral membrane fusion protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2012
From: MANGEOT, PHILIPPE; LOTTEAU, VINCENT
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
Reel/Frame 028923/0049 →
Priority Claims (1)
EP 09306091 · Nov 13, 2009 · regional
Continuity (1)
Related Publication 20120322147A1 · Dec 20, 2012